(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 20.57% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.3%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.21%.
Glaukos's revenue in 2026 is $612,839,000.On average, 17 Wall Street analysts forecast GKOS's revenue for 2026 to be $41,286,396,543, with the lowest GKOS revenue forecast at $36,404,885,916, and the highest GKOS revenue forecast at $43,235,815,660. On average, 17 Wall Street analysts forecast GKOS's revenue for 2027 to be $50,654,225,417, with the lowest GKOS revenue forecast at $46,220,402,873, and the highest GKOS revenue forecast at $55,219,582,141.
In 2028, GKOS is forecast to generate $64,174,523,456 in revenue, with the lowest revenue forecast at $48,093,142,872 and the highest revenue forecast at $73,376,017,628.